Profile data is unavailable for this security.
About the company
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.
- Revenue in CAD (TTM)26.24m
- Net income in CAD-2.77m
- Incorporated2004
- Employees--
- LocationCovalon Technologies Ltd1660 Tech Avenue, Unit 5MISSISSAUGA L4W 5S7CanadaCAN
- Phone+1 (905) 568-8400
- Fax+1 (905) 568-8400
- Websitehttps://covalon.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medexus Pharmaceuticals Inc | 158.95m | 8.08m | 37.91m | 98.00 | 4.24 | 0.9337 | 2.35 | 0.2385 | 0.3659 | 0.3659 | 7.31 | 1.66 | 0.7547 | 2.19 | 5.44 | 1,621,921.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
| Immunoprecise Antibodies Ltd | 23.69m | -14.27m | 37.97m | 102.00 | -- | 0.7618 | -- | 1.60 | -0.4121 | -0.4121 | 0.6832 | 1.38 | 0.2939 | 5.25 | 6.76 | 169,018.60 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |
| Eastwood Bio-Medical Canada Inc | 736.75k | -531.60k | 41.33m | -- | -- | -- | -- | 56.10 | -0.0077 | -0.0077 | 0.0107 | -0.013 | 1.63 | -- | 38.65 | -- | -117.75 | -52.23 | -- | -140.29 | 60.00 | 52.09 | -72.15 | -52.90 | -- | -227.16 | -- | -- | -33.22 | 3.13 | -264.69 | -- | -- | -- |
| IntelGenx Technologies Corp. | 1.44m | -15.15m | 41.92m | 48.00 | -- | -- | -- | 29.04 | -0.0868 | -0.0868 | 0.0083 | -0.1208 | 0.1245 | 14.36 | 1.74 | -- | -130.62 | -75.15 | -- | -133.79 | -66.03 | -- | -1,049.48 | -819.85 | 0.1153 | -4.88 | 23.66 | -- | 9.37 | -10.65 | 7.14 | -- | -30.32 | -- |
| Microbix Biosystems Inc | 23.84m | 4.06m | 44.50m | 69.00 | 10.99 | 1.61 | 8.15 | 1.87 | 0.0296 | 0.0296 | 0.173 | 0.202 | 0.6703 | 1.67 | 6.33 | -- | 11.42 | -0.9729 | 12.72 | -1.17 | 54.38 | 52.30 | 17.04 | -1.55 | 4.98 | 3.53 | 0.1948 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
| MustGrow Biologics Corp | 4.71m | -665.06k | 47.18m | 0.00 | -- | 10.42 | -- | 10.01 | -0.0134 | -0.0134 | 0.0936 | 0.0912 | 0.7632 | -- | 45.31 | -- | -10.77 | -50.41 | -14.00 | -59.28 | -- | -- | -14.11 | -298.73 | -- | -- | 0.1393 | -- | 72,619.13 | 372.54 | 87.84 | -- | -- | -- |
| Covalon Technologies Ltd | 26.24m | -2.77m | 49.88m | -- | -- | 2.48 | -- | 1.90 | -0.1123 | -0.1123 | 1.06 | 0.8021 | 1.02 | 1.84 | 4.53 | -- | -10.83 | -18.06 | -12.67 | -27.10 | 55.84 | 51.89 | -10.57 | -27.06 | 4.85 | -- | 0.0597 | -- | 46.56 | -0.096 | 51.79 | -- | 12.21 | -- |
| KDA Group Inc | 186.28k | 133.66k | 49.99m | -- | 141.79 | 3.22 | 57.22 | 268.35 | 0.002 | 0.0926 | 0.0012 | 0.0886 | 0.0079 | -- | 0.0693 | -- | -0.4146 | -17.96 | -0.8534 | -44.69 | 36.51 | 26.76 | -52.24 | -28.00 | -- | -4.31 | 0.1287 | -- | -22.20 | -62.03 | 106.88 | -- | 31.67 | -- |
| LSL Pharma Group Inc | 12.17m | -4.62m | 51.84m | -- | -- | 3.22 | -- | 4.26 | -0.056 | -0.056 | 0.1466 | 0.1489 | 0.3929 | 2.59 | 4.87 | -- | -14.92 | -- | -21.69 | -- | 19.76 | -- | -37.97 | -- | 0.4505 | -0.8465 | 0.4938 | -- | -- | -- | -- | -- | -- | -- |
| Helix Biopharma Corp. | 0.00 | -5.65m | 58.83m | 9.00 | -- | -- | -- | -- | -0.0277 | -0.0277 | 0.00 | -0.0012 | 0.00 | -- | -- | 0.00 | -318.95 | -261.49 | -574.76 | -- | -- | -- | -- | -- | -- | -2,825.00 | -- | -- | -- | -- | 4.16 | -- | -28.36 | -- |
| Simply Better Brands Corp | 95.08m | -30.01m | 59.65m | -- | -- | -- | -- | 0.6274 | -0.4156 | -0.4305 | 1.32 | -0.0854 | 2.71 | 12.68 | 17.69 | -- | -85.10 | -63.90 | -361.23 | -215.48 | 53.52 | -- | -31.40 | -29.46 | 0.2536 | -19.65 | 3.20 | -- | 22.08 | -- | -96.41 | -- | -- | -- |
| Satellos Bioscience Inc | 0.00 | -21.13m | 60.91m | 12.00 | -- | 1.77 | -- | -- | -0.1718 | -0.1718 | 0.00 | 0.3059 | 0.00 | -- | -- | 0.00 | -93.29 | -107.22 | -109.86 | -136.58 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -40.33 | -- | 459.46 | -- |
